Deals Of The Week: Sun/Dusa; Pfizer/Alliance For Lupus Research; Merck/Regenstrief Institute
Executive Summary
Preclinical protein platform play Envoy got taken out by Takeda last week for up to $140 million. That magical “up to” typically hides a multitude of sins, but here that may not be the case.